This website sets cookies which are used to offer a personalized experience on our website, generate statistics, and realize advertising or social network tracking. Find out more about our Privacy & Cookie policy and how to manage them on your browser. You can change your cookie settings at any time.



Dr. Hossein A. Ghanbari

Chairman & CSO
Sensei Biotherapeutics


 Hossein A. Ghanbari is a co-founder of Panacea Pharmaceuticals and now serves as its CEO, President, Chief Scientific Officer, and Chairman of the Board.  The Company has three drug candidates for cancer (immunotherapy), one of which is currently in Phase 1 clinical trials, and another candidate for treating neural damage (treatment of chemotherapy-induced cognitive impairment).  Panacea has developed diagnostic tests for prostate cancer (PC Detect®), breast cancer (BC DetectSM), lung cancer (LC Detect®), and colorectal cancer (CC DetectSM).  LC Detect was selected as one of 2007’s Top 10 Medical Breakthroughs by Timemagazine.  Panacea also has a late-stage pre-clinical cancer imaging program to complete its integrated cancer management approach.